CCM
PTX

Consonance Capital Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Consonance Capital Management’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-326,148
Closed -$34.9M – 31
2015
Q1 		$34.9M Sell
326,148
-16,631
-5% -$1.59M 3.17% 13
2014
Q4 		$32.2M Sell
342,779
-1,535
-0.4% -$146K 4.15% 10
2014
Q3 		$26.4M Buy
344,314
+41,829
+14% +$3.29M 3.63% 11
2014
Q2 		$27.2M Buy
302,485
+180,765
+149% +$11.1M 4.04% 12
2014
Q1 		$6.51M Buy
+121,720
New +$4.02M 0.97% 25

Other funds holding PTX

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Consonance Capital Management's PTX Position: Q2 2015 in Review

Consonance Capital Management sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2015, closing a stake of 326,148 shares — an estimated $34.9M sold.

Consonance Capital Management first reported a position in PTX in Q1 2014 and held it in 5 quarters. The position peaked at $34.9M in Q1 2015. 114 funds tracked by Wall St. Rank hold PTX as of Q2 2015.

  • Consonance Capital Management reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2015 after selling out during the quarter.
  • Consonance Capital Management sold 326,148 Pernix Therapeutics Holdings, Inc. shares in Q2 2015, an estimated $34.9M.
  • Consonance Capital Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q1 2014 and held it in 5 quarters.
  • Consonance Capital Management's Pernix Therapeutics Holdings, Inc. position peaked at $34.9M in Q1 2015.
  • 114 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2015.

Based on Consonance Capital Management's 13F filing for Q2 2015, filed 12 Aug 2015.